Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 Oct;20(4):317–321. doi: 10.1111/j.1365-2125.1985.tb05070.x

The pharmacokinetics of L-tryptophan following its intravenous and oral administration.

A R Green, J K Aronson, P J Cowen
PMCID: PMC1400876  PMID: 4074600

Abstract

The pharmacokinetics of L-tryptophan (5 g and 7.5 g) have been studied after its intravenous administration to healthy subjects and the results compared with those obtained after oral administration (0.7 g-3.5 g). In order to do this, we have re-analysed previously published data relating to oral administration. The data obtained following the oral administration of L-tryptophan suggest that the total body clearance and apparent volume of distribution are saturable. The pharmacokinetics of tryptophan after intravenous administration of 5 g and 7.5 g were similar to those after the oral administration of 25 and 50 mg kg-1 (i.e. 1.75 g and 3.5 g). Similar pharmacokinetic values were obtained following intravenous tryptophan when the same subjects were retested after a period of 2-4 weeks.

Full text

PDF
317

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Denckla W. D., Dewey H. K. The determination of tryptophan in plasma, liver, and urine. J Lab Clin Med. 1967 Jan;69(1):160–169. [PubMed] [Google Scholar]
  2. Gibaldi M., Perrier D. Drug elimination and apparent volume of distribution in multicompartment systems. J Pharm Sci. 1972 Jun;61(6):952–954. doi: 10.1002/jps.2600610630. [DOI] [PubMed] [Google Scholar]
  3. Green A. R., Aronson J. K., Curzon G., Woods H. F. Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan. Br J Clin Pharmacol. 1980 Dec;10(6):603–610. doi: 10.1111/j.1365-2125.1980.tb00516.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Green A. R., Aronson J. K., Curzon G., Woods H. F. Metabolism of an oral tryptophan load. II: Effect of pretreatment with the putative tryptophan pyrrolase inhibitors nicotinamide or allopurinol. Br J Clin Pharmacol. 1980 Dec;10(6):611–615. doi: 10.1111/j.1365-2125.1980.tb00517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Green A. R., Aronson J. K. Metabolism of an oral tryptophan load III: effect of a pyridoxine supplement. Br J Clin Pharmacol. 1980 Dec;10(6):617–619. doi: 10.1111/j.1365-2125.1980.tb00518.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Green A. R., Woods H. F., Joseph M. H. Tryptophan metabolism in the isolated perfused liver of the rat: effects of tryptophan concentration, hydrocortisone and allopurinol on tryptophan pyrrolase activity and kynurenine formation. Br J Pharmacol. 1976 May;57(1):103–114. doi: 10.1111/j.1476-5381.1976.tb07660.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jusko W. J., Gibaldi M. Effects of change in elimination on varous parameters of the two-compartment open model. J Pharm Sci. 1972 Aug;61(8):1270–1273. doi: 10.1002/jps.2600610820. [DOI] [PubMed] [Google Scholar]
  8. KNOX W. E., AUERBACH V. H. The hormonal control of tryptophan peroxidase in the rat. J Biol Chem. 1955 May;214(1):307–313. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES